Crossref
Bispecific Antibody-Drug Conjugates in Oncology: Design Principles, Clinical Progress, and Challenges
Current Pharmacology Reports · 22.08.2026 · 12 (1)
DOI: 10.1007/s40495-026-00476-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Pharmacology Reports, online erschienen am 22.08.2026. Verfasst von Vaishali Verma und 2 weiteren Autor:innen. Die Arbeit nennt 109 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Verma, V., Sinha, N., & Kasana, A. (2026). Bispecific Antibody-Drug Conjugates in Oncology: Design Principles, Clinical Progress, and Challenges. Current Pharmacology Reports, 12(1). https://doi.org/10.1007/s40495-026-00476-9
Vancouver
Verma V, Sinha N, Kasana A. Bispecific Antibody-Drug Conjugates in Oncology: Design Principles, Clinical Progress, and Challenges. Current Pharmacology Reports. 2026;12(1). doi:10.1007/s40495-026-00476-9
BibTeX
@article{Verma2026,
author = {Verma, Vaishali and Sinha, Nimisha and Kasana, Abhishek},
title = {Bispecific Antibody-Drug Conjugates in Oncology: Design Principles, Clinical Progress, and Challenges},
journal = {Current Pharmacology Reports},
year = {2026},
volume = {12},
number = {1},
doi = {10.1007/s40495-026-00476-9}
}
EUVIMED